Biotest Aktiengesellschaft
Save
1.33B
Market cap
23.7x
Current P/E
526.32x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
Similar securities
Based on sector and market capitalization
Report issue